Structure

1-(2-Tetrahydropyranyl)-1H-pyrazole-4-boronic acid neopentyl glycol ester

CAS
1072944-26-3
Catalog Number
ACM1072944263
Category
Other Products
Molecular Weight
264.1
Molecular Formula
C13H21BN2O3

If you have any other questions or need other size, please get a quote.

  • Product Description
  • Case Study
  • Custom Reviews
  • Custom Q&A
  • Synthetic Use
  • Related Resources

Specification

Synonyms
1072944-26-3, 1-(2-TETRAHYDROPYRANYL)-1H-PYRAZOLE-4-BORONIC ACID NEOPENTYL GLYCOL ESTER, 4-(5,5-DIMETHYL-1,3,2-DIOXABORINAN-2-YL)-1-(TETRAHYDRO-2H-PYRAN-2-YL)-1H-PYRAZOLE, CTK6B2291, MolPort-002-054-877, ANW-41725, AG-A-67918, 1-(THP)-4-(Neopentylglycolato)-pyrazole, A-4438, 1-(2-Tetrahydropyranyl)-1H-pyrazole-4-boronic acid neopentyl glycol ester,, 1-(2-Tetrahydropyranyl)-1H-pyrazole-4-boronic acid neopentylglycol ester, 1-(Tetrahydro-2H-pyran-2-yl)-4-(5,5-dimethyl-[1,3,2]dioxaborinan-2-yl)-pyrazole
IUPAC Name
4-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-1-(oxan-2-yl)pyrazole
SMILES
B1(OCC(CO1)(C)C)C2=CN(N=C2)C3CCCCO3
InChI Key
YVZAPDBXQZXBDN-UHFFFAOYSA-N
Boiling Point
424.3ºC at 760 mmHg
Flash Point
210.4ºC
Density
1.2g/cm³
Exact Mass
264.16500
H-Bond Acceptor
4
H-Bond Donor
0

Downstream Synthesis Route 1

  • 1072944-26-3
  • 2280839-84-9
  • 2280848-54-4

Reference: [1]Current Patent Assignee: TAISHO PHARMACEUTICAL HOLDINGS CO LTD - EP3666766, 2020, A1
Location in patent: Paragraph 1250

Downstream Synthesis Route 2

  • 1072944-26-3
  • 2415255-70-6
  • 2415255-71-7

Reference: [1]Current Patent Assignee: ONO PHARMACEUTICAL CO LTD - US2021/253615, 2021, A1
Location in patent: Paragraph 0156; 0407-0409

* For details of the synthesis route, please refer to the original source to ensure accuracy.

Please kindly note that our products are for research use only.

Alfa Chemistry

For product inquiries, please use our online system or send an email to .

Alfa Chemistry
Shopping basket
Loading...
Loading...
Download PDF documentDownload
* I hereby give my consent that I may receive marketing e-mails with information on existing and new services from this company. I know that I can opt-out from receiving such e-mails at any time or by using the link which will be provided in each marketing e-mail.